Sean D. Regnier - Publications
Affiliations: | 2017- | Psychology | Western Michigan University, Kalamazoo, MI, United States |
Year | Citation | Score | |||
---|---|---|---|---|---|
2023 | Regnier SD, Shellenberg TP, Koffarnus MN, Cox DH, Lile JA, Rush CR, Stoops WW. Cocaine abstinence during the "critical period" of a contingency management trial predicts future abstinence in people with cocaine use disorder. Drug and Alcohol Dependence. 253: 111030. PMID 38006674 DOI: 10.1016/j.drugalcdep.2023.111030 | 0.353 | |||
2023 | A Schulz J, Regnier SD, Erath TG, Mullis LC, Nugent A, Atwood GS, Villanti AC. Smoking cessation interventions for U.S. adults with disabilities: A systematic review. Addictive Behaviors. 149: 107905. PMID 37977010 DOI: 10.1016/j.addbeh.2023.107905 | 0.332 | |||
2023 | Regnier SD, Rzeszutek MJ, Strickland JC, Shellenberg TP, Stoops WW. The endowment effect and temporal discounting of drug and non-drug commodities. Pharmacology, Biochemistry, and Behavior. 173638. PMID 37717822 DOI: 10.1016/j.pbb.2023.173638 | 0.602 | |||
2022 | DeFulio A, Brown HD, Davidson RM, Regnier SD, Kang N, Ehart M. Feasibility, Acceptability, and Preliminary Efficacy of a Smartphone-Based Contingency Management Intervention for Buprenorphine Adherence. Behavior Analysis in Practice. 16: 450-458. PMID 37187840 DOI: 10.1007/s40617-022-00730-8 | 0.657 | |||
2022 | Regnier SD, Traxler HK, Devoto A, DeFulio A. A Systematic Review of Treatment Maintenance Strategies in Token Economies: Implications for Contingency Management. Perspectives On Behavior Science. 45: 819-861. PMID 36618564 DOI: 10.1007/s40614-022-00358-7 | 0.403 | |||
2022 | Regnier SD, Strickland JC, Stoops WW. A preliminary investigation of schedule parameters on cocaine abstinence in contingency management. Journal of the Experimental Analysis of Behavior. PMID 35538731 DOI: 10.1002/jeab.770 | 0.355 | |||
2022 | Regnier SD, DeFulio A. Implications of epidemic-pandemic convergence for routine care adoption of contingency management: A case study. Experimental and Clinical Psychopharmacology. PMID 35482630 DOI: 10.1037/pha0000569 | 0.641 | |||
Show low-probability matches. |